Glenmark Pharmaceuticals rises on turning black in Q3
Glenmark Pharmaceuticals is currently trading at Rs. 1386.45, up by 11.80 points or 0.86% from its previous closing of Rs. 1374.65 on the BSE.
The scrip opened at Rs. 1374.65 and has touched a high and low of Rs. 1388.00 and Rs. 1364.50 respectively. So far 7230 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1830.05 on 15-Oct-2024 and a 52 week low of Rs. 853.15 on 19-Feb-2024.
Last one week high and low of the scrip stood at Rs. 1452.90 and Rs. 1280.00 respectively. The current market cap of the company is Rs. 38913.75 crore.
The promoters holding in the company stood at 46.65%, while Institutions and Non-Institutions held 37.40% and 15.96% respectively.
Glenmark Pharmaceuticals has reported net profit at Rs 413.80 crore for third quarter ended December 31, 2024 (Q3FY25) as compared to net loss of Rs 20.41 crore for the same quarter in the previous year. Total income of the company increased by 46.59% at Rs 2380.47 crore for Q3FY25 as compared to Rs 1623.91 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported net profit at Rs 347.96 crore for the quarter ended December 31, 2024 as compared to net loss of Rs 351.37 crore for the same quarter in the previous year. Total income of the company increased by 33.96% at Rs 3418.68 crore for Q3FY25 as compared to Rs 2552.11 crore for the corresponding quarter previous year.
